Genen­tech's food al­ler­gy med­ica­tion gets pri­or­i­ty re­view nod from the FDA

Genen­tech and No­var­tis’ Xo­lair scored a pri­or­i­ty re­view from the FDA on Wednes­day for the re­duc­tion of al­ler­gic re­ac­tions in adult …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.